rs8234

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000218.3(KCNQ1):​c.*875A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.393 in 453,932 control chromosomes in the GnomAD database, including 38,610 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12571 hom., cov: 34)
Exomes 𝑓: 0.39 ( 26039 hom. )

Consequence

KCNQ1
NM_000218.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.637

Publications

31 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1-AS1 (HGNC:42790): (KCNQ1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.838 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ1NM_000218.3 linkc.*875A>G 3_prime_UTR_variant Exon 16 of 16 ENST00000155840.12 NP_000209.2 P51787-1Q96AI9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkc.*875A>G 3_prime_UTR_variant Exon 16 of 16 1 NM_000218.3 ENSP00000155840.2 P51787-1

Frequencies

GnomAD3 genomes
AF:
0.391
AC:
59445
AN:
152012
Hom.:
12562
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.424
Gnomad AMI
AF:
0.331
Gnomad AMR
AF:
0.475
Gnomad ASJ
AF:
0.385
Gnomad EAS
AF:
0.859
Gnomad SAS
AF:
0.492
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.440
Gnomad NFE
AF:
0.312
Gnomad OTH
AF:
0.408
GnomAD2 exomes
AF:
0.446
AC:
58181
AN:
130514
AF XY:
0.441
show subpopulations
Gnomad AFR exome
AF:
0.432
Gnomad AMR exome
AF:
0.553
Gnomad ASJ exome
AF:
0.378
Gnomad EAS exome
AF:
0.872
Gnomad FIN exome
AF:
0.368
Gnomad NFE exome
AF:
0.313
Gnomad OTH exome
AF:
0.399
GnomAD4 exome
AF:
0.395
AC:
119100
AN:
301802
Hom.:
26039
Cov.:
0
AF XY:
0.400
AC XY:
68770
AN XY:
171994
show subpopulations
African (AFR)
AF:
0.425
AC:
3639
AN:
8554
American (AMR)
AF:
0.552
AC:
15059
AN:
27274
Ashkenazi Jewish (ASJ)
AF:
0.381
AC:
4108
AN:
10786
East Asian (EAS)
AF:
0.870
AC:
8009
AN:
9210
South Asian (SAS)
AF:
0.478
AC:
28525
AN:
59650
European-Finnish (FIN)
AF:
0.367
AC:
4544
AN:
12374
Middle Eastern (MID)
AF:
0.390
AC:
449
AN:
1150
European-Non Finnish (NFE)
AF:
0.311
AC:
49382
AN:
158762
Other (OTH)
AF:
0.383
AC:
5385
AN:
14042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
6648
13297
19945
26594
33242
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
456
912
1368
1824
2280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.391
AC:
59495
AN:
152130
Hom.:
12571
Cov.:
34
AF XY:
0.399
AC XY:
29669
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.424
AC:
17598
AN:
41482
American (AMR)
AF:
0.475
AC:
7264
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.385
AC:
1335
AN:
3472
East Asian (EAS)
AF:
0.859
AC:
4444
AN:
5174
South Asian (SAS)
AF:
0.491
AC:
2370
AN:
4824
European-Finnish (FIN)
AF:
0.373
AC:
3947
AN:
10570
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.312
AC:
21239
AN:
68006
Other (OTH)
AF:
0.409
AC:
864
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1865
3730
5596
7461
9326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.354
Hom.:
15571
Bravo
AF:
0.402
Asia WGS
AF:
0.627
AC:
2176
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22199116, 27531917) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Long QT syndrome 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Atrial fibrillation, familial, 3 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Jervell and Lange-Nielsen syndrome 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Short QT syndrome type 2 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Congenital long QT syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Long QT syndrome Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.068
DANN
Benign
0.41
PhyloP100
-0.64
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8234; hg19: chr11-2870108; API